A new type of synthetic inhibitor of DNA topoisomerase I and II was examined and several of these derivatives exhibited strong dual activity against these enzymes. This series of compounds showed high cytotoxic activities against cancer cells, but only a limited number of compounds showed any noticeable activity in an in vivo test against murine P388. Non-specific toxicity was observed in the in vivo tests.
DNA topoisomerase has been a prime target for discovery of anticancer drugs 2) and the efforts in this area have been fruitful in providing some useful anticancer agents.
3) There are two types of DNA topoisomerase enzymes, type I (top I) and II (top II) which are classified according to whether they function by changing the topology of DNA helices by breaking one strand (top I) or two strands (top II) of the double helix. Most of the marketed topoisomerase inhibitors originated in natural products, and the number of totally synthetic agents is quite few compared with naturally-derived ones. Efforts at finding inhibitors has focused on the discovery of selective inhibitors of two types of topoisomerase, and the number of studies on dual inhibitors is quite limited. 4) We have been involved in the chemistry of pyrazolo [1,5-a] indoles with the hope of discovering biologically active compounds. 5) In this context, we have prepared a series of compounds and found that some derivatives have fairly strong inhibitory activity against DNA topoisomerase I and II, and have strong cytotoxic activity against cancer cells. We report these findings in this paper.
Chemistry We reported the preparation and characterization of 1-methyl-1H-pyrazolo [1,5-a] indole 1 as an isoelectronic analogue of azulene, 6) i.e., pseudoazulene, 7) by treatment of the acid salt 6 with strong base (Chart 1). The organic salts of pseudoazulene were reported to condense with aldehyde via pseudoazulene to give condensation products. 8) Three kinds of reaction conditions were employed for this condensation: a) refluxing in acetic acid, b) refluxing with piperidine in ethanol and c) refluxing with sodium methoxide in methanol. When we adopted the condition a) to the reaction of 6 6) with p-dimethylaminobenzaldehyde (10), the product 13 was obtained in 80% yield (Chart 2). The structure of 13 was supported from the 1 H-NMR spectrum, in particular the characteristic singlet signals for 10-H at d 8.30 and 3-H at d 7.45 together with two singlet N-Me signals at d 3.11 (NMe 2 ) and 4.43 (NMe). Further support for this structure was obtained from the 13 C-NMR spectrum, i.e., C-3 at d 101.5 and C-10 at d 140.0 ppm. The geometry of the side chain of 13 was determined to be Z from the following observations. When this condensation reaction was halted at shorter reaction time (1.5 h) , the product was a mixture of two isomers (ca. 1 : 1). It was not possible to separate these isomers, but the detection of additional singlet signals for 10-H (d 8.28 ppm) and 3-H (d 7.49) for an isomer besides the signals for 13 in the 1 H-NMR spectrum supported the contamination by the isomer. Longer reaction times gave a single isomer 13 as the sole product, with total disappearance of the signals observed in incomplete reaction product. Since the Zisomer is more stable than the E-isomer according to molecular modeling, the stereochemistry of 13 was determined to be Z-form. A similar stereochemical result was obtained with the product 12 and its stereochemistry was supported by the nuclear Overhauser effect spectroscopy spectrum (NOESY), vide infra. Compound 13 attracted our interest since molecular modeling revealed conformational similarity of 13 with 4-(9-acridinylamino)-N-methansulfonyl-m-anisidine (m-AMSA) (Chart 3) which is an anticancer agent clinically used nowadays. The preliminary cytotoxic activity for 13 showed promising results, thus we decided to prepare a series of this compound, as shown in Chart 2.
Compounds 12 and 14 were prepared in a similar manner as in 13. The NOESY spectrum of 12 indicated nuclear Overhauser effects (NOE) between 3-H and aromatic protons on 10-phenyl group, and between 5-H and 10-H, thus supporting the Z-geometry.
For the preparation of 2-alkyl substituted derivatives, the quaternary salts 7 and 8 were prepared as shown in Chart 1. Dehydrogenation of tetrahydro derivative 2 9a) with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) gave 4 and methylation with methyl trifluoromethanesulfonate (methyl triflate) gave salt 7. Dehydration of 3 9b) to 5 (methanesulfonyl chloride and triethylamine) and methylation of 5 gave 8 in good yield. The subsequent condensations of 7 and 8 with aldehyde 10 gave the products 15 and 16, respectively. The yield in the condensation ranged from 51% to 99%. As the nitroso group can behave like an aldehyde in this type of coupling reaction, 10) 4-dimethylaminonitrosobenzene (17) was also employed in the above condensation reaction to introduce a nitrogen atom at position 10. Thus, the reaction of 6 with 17 under similar reaction conditions gave the product 18 in 90% yield. The imino group of 18 was reactive but an attempt at cleaving (acid hydrolysis) or reducing (sodium borohydride) the imino group of 18 led to intractable mixtures. In order to deduce the role of the five-membered ring of the indole nucleus of 13 in the biological activity the open-ring compound 20 was also prepared. The reaction of salt 19 with 10 in the presence of sodium ethoxide in ethanol, as reported, 8c) gave 20. The UV spectrum of 20 revealed that there is more effective electron delocalization in open-ring compound 20 than in the closed-ring compound 13. Thus the l max of 20 appeared at higher wavelength (408 nm, log e 4.64) than that of 13 (323 nm, log e 4.03) with stronger absorption. The flexible side chain of 20 can allow better electron delocalization than that for 13. The presence of the conjugated system in 13 was confirmed by reduction, i.e., the interruption of conjugation. When 13 was reduced with sodium borohydride in deuterated dimethyl sulfoxide , the color of the solution changed from dark red to colorless (deconjugation) and the formation of the saturated product 21 was detected in the NMR spectra (Chart 4). In the The UV-VIS spectrum of the reduction product 21 was obtained by adding sodium borohydride to a solution of 13 in ethanol. Bathchromic shifts of l max absorptions were observed, but they appeared at about 30 nm lower wavelength than those of 1.
6) Attempts at both isolating and derivatizing 21 after reduction failed and led to recovery of the starting salt 13 ( 1 H-NMR identification). A similar reduction was reported to be successful with conjugated 3-phenylmethyleneoxyindoles.
11) Hydrolysis of 13 in acid or base resulted in the recovery of 13.
Biological Activity Inhibition tests for the compounds 12-16, 18 and 20 against DNA topoisomerase I (top I) and II (top II) were carried out by measuring the relaxation of superhelical DNA.
12) The activity was evaluated as IC 50 (mg/ml) and the results are summarized in Tables 1 and 2 . The commercial antitumor agents and were employed as references for the selective inhibition of top I (SN-38) and top II (VP-16). As shown in Table 1 , all compounds, except 20, displayed quite strong inhibitory activities against human DNA topoisomerases. The activity of compounds 13 and 18 were comparable, and about ten times stronger than the reference compounds. These compounds possessed activity against both types of DNA topoisomerases, and are unique in this sense among compounds having a quaternary nitrogen atom.
13) Lower activity against both topoisomerases was observed for 15 and 16. When the source of topoisomerase was different (Table 2 ), the relative inhibitory activity varied but the activity of 13 remained strong. Compound 13 was more selective for top II obtained from murine P388 cancer cells. The poor inhibitory activity of 20 against top I and II ( Table  1 ), indicates that the tricyclic system is important for high activity. However, introduction of a nitrogen at C-10, as in compound 18 did not alter the activity.
The cytotoxic activities of the above products were tested by measuring the proliferation of cancer cells in the presence of drug by the microculture tetrazolium method.
14) Separate experiments were conducted for two series of compounds and the results are summarized in Table 3 .
The activity was expressed as GI 50 (ng/ml). Anticancer drugs in clinical use, 5-fluorouracil (5-FU) and cisplatin (CDDP), were employed as reference compounds. Topoisomerase inhibition was principally reflected in the cytotoxic activity. The potencies of 13 and 16 were notable compared with the reference compounds and corresponded well with the inhibitory activities against topoisomerases ( Table 1) . The cytotoxicity of imine 18 was weak compared with that of 13. The possible susceptibility of the imine 18 to hydrolysis under biological conditions may be the reason for reduced cytotoxicity. The cytotoxic activity of open ring compound 20 was comparable to the other compounds, even though poor inhibitory activity was observed against topoisomerases. However, the basic trend observed in these tricyclic compounds supports the hypothesis that topoisomerase inhi- a) Dose (mg/kgϫ2). Ascitic fluid containing 1ϫ10 6 cells was inoculated i.p. into CSDF1 mice (day 0), and the compound in BTC suspension was administered i.p. at day 1 and 5. b) Survival days range. c) MST (mean survival terms in days). d) ILS (increase of life span in %). e) Number of mice that died by toxicity after the operation, over the number of mice tested. The rest of the mice all died after the days indicated. a) See the notation in Table 3. bition may play an important role in cytotoxic activity. The principal role of the substituent at C-4 of this series of compounds on cytotoxic activity was investigated with the skeletal compound, 1-methyl-4H-pyrazolo [1,5-a] indolenium salt. The cytotoxicity of the salt with different substituents at C-2, 6 (2-phenyl), 7 (2-methyl) and 8 (2-styryl) against cancer cells is cited in Table 4 . It is apparent from this table that the presence of a C-4 substituent is important for expressing cytotoxic acitvities. The weak activity of 8 suggests the possiblity of improving cytotoxic activities by introducing a suitable substituent at the C-2 position. The in vivo antitumor activity against P388 was also investigated. P388 cells were inoculated interperitoneally (i.p.) into CDF1 male mice and the drugs were given i.p. on days 1 and 5. Survival was monitored daily and the increase in life span (ILS) was calculated using the control group. The results are listed in Table 5 . A favorable ILS value (38%) was obtained for 16 at a dose of 1 mg/kg. Small ILS values, 22% and 26%, were observed for 13 and 15 respectively. Dose escalation did not improve the ILS values probably due to the non-specific toxicity of the compounds. A good result both in in vitro and in vivo tests was obtained with 16. The mechanism of DNA topoisomerase inhibition has not been clarified yet, but in a preliminary experiment, the binding of compound 13 to calf thymus DNA was detected by UV-VIS spectra, suggesting a possible cause of inhibition. It is essential to resolve the mechanism of inhibition of topoisomerase I and II for the exploration of new types of antitumor agents. Also, analysis of structure-activity relationships (SAR) and subsequent removal of non-specific toxicity are an essential requirement for discovering a potential antitumor agent.
Experimental
Melting points (mp) were determined on a Yanaco micro-melting point apparatus without correction. Infrared spectra (IR) (KBr pellet unless stated otherwise) were measured with a Perkin-Elmer FT-IR 1720. Ultraviolet-Visible spectra were recorded on a Shimadzu UV-200S double beam spectrophotometer.
1 H-and 13 C-nuclear magnetic resonance spectra (NMR) were obtained at ambient temperature (25-27°C) with JEOL JNM-FT 200 and JNM-ALPHA 400 instrument in CDCl 3 , unless otherwise specified, with tetramethylsilane as an internal standard. Mass spectra (MS) and high resolution MS (HR-MS) were recorded on a Hitachi RMU-7MG and the figures in parentheses indicate the relative intensities. Anhydrous tetrahydrofuran (THF) was prepared by distilling in the presence of ketyl radical and dry acetonitrile by distilling from calcium hydride.
1,2-Dimethyl-4H-pyrazolo[1,5-a]indolium Trifluoromethanesulfonate (7) 2-Methyl-1,2,3,3a-tetrahydro-4H-pyrazolo [1,5-a] indole (2) 9a) (2.23 g, 12.8 mmol) and DDQ (6.39 g, 28.2 mmol) in dry dichloromethane (80 ml) was stirred at room temperature for 2 h. Dilution with ether (30 ml), filtration to remove insoluble material, washing of the filtrate (aqueous 10% NaOH solution and saturated brine), drying (anhydrous sodium sulfate) and evaporation in vacuo gave 2-methyl-4H-pyrazolo [1,5-a] indole (4) 7, 125.7, 127.9, 133.1, 140.6, 145.4, 153.7. A solution of the above product 4 (0.500 g, 2.9 mmol) in dry dichloromethane (20 ml) was reacted with methyl trifluoromethanesulfonate (2.66 ml, 23.5 mmol) in two portions (interval 42 h). The precipitated crystals (0.900 g, 91.6%) were recrystallized to give 7 (0. 
1-Methyl-2-E-styryl-4H-pyrazolo[1,5-a]indolium Trifluoromethane-sulfonate (8) 2-E-Styryl-3-hydroxy-3a,4-dihydro-4H-pyrazolo[1,5-a]indole (3)
9b) (0.63 g, 2.1 mmol) was reacted with methanesulfonyl chloride (0.25 ml, 3.1 mmol) and triethylamine (0.60 ml, 4.3 mmol) in dry dichloromethane (38 ml) at ice-cooling temperature for 4 h. The solution was diluted with water, basified with sodium carbonate and extracted with dichloromethane. The organic layer was washed (saturated brine), dried (anhydrous sodium sulfate), and evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel 20 g, hexane-ethyl acetate 5 : 1) to give 2-E-styryl-4H-pyrazolo [1,5-a] indole (5) The above product 5 (1.00 g, 3.87 mmol) was reacted with methyl trifluoromethanesulfonate (0.88 ml, 7.74 mmol) as described above and crystallization of the product from MeOH-EtOAc gave the salt 8 (1.345 g, 82.2%), mp 223.5-225.0°C (MeOH-EtOAc). IR cm
Ϫ1
: 1539, 1468, 1291, 1247, 1224, 1154, 1027, 756, 747, 635 . (6) 6) (0.30 g, 0.82 mmol) and p-dimethylaminobenzaldehyde (10) (0.14 g, 0.94 mmol) in acetic acid (30 ml) was refluxed for 20 h under an atmosphere of nitrogen. The solution was concentrated under reduced pressure and the residue was crystallized from ethanol to give 13 as dark red-purple crystals (0.32 g, 80%), mp 237. 1, 112.2, 120.8, 121.2, 122.6, 125.9, 126.7, 127.4, 129.3, 129.6, 131.2, 131.6, 132.4, 133.4, 141.9, 151.6, 152.5. Anal. Calcd for C 27 H 24 F 3 N 3 O 3 S: C, 61.47; H, 4.59; N, 7.97. Found: C, 61.44; H, 4.66; N, 7. 98. E-Isomer of 13, C-NMR (DMSO-d 6 ) d: 37.5*, 39.5*, 101.5*, 112. 1, 112.3, 112.6, 120.8, 121.2, 126.0, 126.7, 127.4, 129.3*, 129.6*, 131.2, 131.6, 132.5, 133.4, 140.0, 142.0, 151.6, 152.6 . The signals marked with an asterisk overlapped with those of the Z isomer.
1-Methyl-2-phenyl-4-phenylmethylene-4H-pyrazolo[1,5-a]indolium Trifluoromethanesulfonate (12)
The salt 6 (0.50 g, 1.26 mmol) and benzaldehyde (9) (0.17 ml, 1.67 mmol) were reacted in acetic acid (50 ml) for 20 h and purified as described above to give 12 (0.61 g, 99.8%), mp 233.0-235.0°C (CH 2 Cl 2 -iso-Pr 2 O). UV-VIS l max MeOH nm (log e): 270 (4.38), 356 (4.34). IR cm
Ϫ1
: 1627, 1544, 1467, 1383, 1263, 1226, 1157, 1034, 766, 700 . , 62.07; H, 3.95; N, 5.78%. Found: C, 62.07; H, 4. (1H, s, 10-H) .
13 C-NMR (DMSO-d 6 ) d: 37.9, 103.9 (C-3), 113.3, 123.1, 123.2, 124.6, 125.4, 127.7, 129.3 (Cϫ2), 129.6 (Cϫ2), 130.0, 130.5, 130.8 (Cϫ2), 131.5, 134.7, 135.5 (C-10), 140.1, 141.4 11.6, 35.7, 101.5, 111.8 (Cϫ2), 112.1, 112.8, 120.8, 120.1, 126.3, 127.3, 131.2, 132.6, 132.9 (Cϫ2), 141.9, 150.3, 152.3. Anal. Calcd for C 22 H 22 F 3 N 3 O 3 S: C, 56.76; H, 4.77; N, 9.03. Found: C, 56.57; H, 4.64; N, 9.03 . 6.96 (2H, d, Jϭ8.8 Hz), m), m), m), 8.24 (1H, s, . 112.5, 120.9, 121.1, 126.4, 127.4, 127.9 (2ϫC), 128.88 (Cϫ2), 128.90, 131.8 (2ϫC), 132.6, 133.3 (Cϫ2), 135.2, 139.2, 142.1, 149.7, 152.4. Anal. Calcd for C 29 H 26 F 3 N 3 O 3 S: C, 62.92; H, 4.73; N, 7.59. Found: C, 62.46; H, 4.65; N, 7. : 1618, 1551, 1364, 1261, 1151, 1030, 773, 638. 1 H-NMR d: 3.08 (6H, s, NMe 2 ), 4.45 (3H, s, NMe), 6.90 (2H, d, Jϭ9 Hz), 7.23 (1H, s, 7.45 (2H, d, Jϭ9.0 Hz), 7.61 (1H, t, Jϭ7.6 Hz), m), 8.08 (1H, d, Jϭ7.4 Hz), 8.15 (1H, d, Jϭ8.0 Hz) .
4-(4-
13 C-NMR d: 38.0 (NMe 2 ), 39.7 (NMe), 104. 2, 112.2 (2ϫC), 113.3, 123.4, 125.2, 125.7 (2ϫC), 128.2, 129.3 (2ϫC), 129.5 (2ϫC), 129.9, 131.52, 131.58, 135.7, 136.32, 136.39, 138.8, 151.0, 152.4. Anal. Calcd for C 26 H 23 and 10 (0.45 g, 3.00 mmol) in ethanol containing sodium ethoxide, prepared by dissolving sodium metal (45.0 mg, 1.96 mmol) in dry ethanol (30 ml) was heated to reflux for 7 h. After removal of solvent, the residue was dissolved in dichloromethane and worked up to give the crude product (0.77 g). Column chromatography (silica gel, 1, 118.8, 119.0, 127.1, 127.4 (2ϫC), 128.7 (2ϫC), 129.0, 129.1 (2ϫC), 129.8, 129.9, 137.6, 148.8, 153.6 . UV-VIS l max EtOH-NaBH 4 nm (log e): 210 (end absorption, 4.51), 229 (4.41), 264 (4.46), 322 (4.00), 397 (3.95); l min EtOH-NaBH 4 nm (log e): 221 (4.40), 243 (4.36), 296 (3.90), 350 (3.70) .
Topoisomerase Inhibition Test Commercial DNA topoisomerase I and II (TopoGen, U.S.A.) were used for the assays and activity was measured by the relaxation of super helical DNA.
12) DNA topoisomerase I and II from murine leukemia P388 were prepared as described by Ishii et al. 15) The assay mixture (20 ml) containing 25 mM Tris-HCl (pH 7.5), 50 mM KCl, 5 mM MgCl 2 , 0.25 mM EDTA disodium salt, 0.25 mM dithiothreitol (DTT), 15 mg/ml bovine serum albumin (plus 10 mM ATP for top II test), and enzyme (sufficient units for relaxing 0.5 mg of SV40 DNA) was used as control. The assay mixture was treated with test sample in DMSO (0.5 ml) and left at 37°C for 10 min, then treated with 0.5 mg of SV40 DNA, and incubated for 10 min. The reaction was terminated by addition of 5 ml of a solution containing 1% sodium dodecylsulfate (SDS), 20 mM EDTA disodium salt and 0.5 mg/ml proteinase K and by incubation for 30 min. Then the solution was mixed with a buffer solution (5 ml) containing 10 mM Na 2 HPO 4 , 31.3% sucrose and 0.3% bromophenolblue, and subjected to electrophoresis (50 mA, 20 V, overnight) on 0.8% agarose gel plates equilibrated with 2 mg/ml chloroquine, 10 mM EDTA, 30 mM Na 2 HPO 4 and 36 mM Tris-HCl (pH 7.8). The plates were stained with 0.05% ethidium bromide solution and photographed under UV light (302 nm). The IC 50 value is expressed as the concentration which caused 50% inhibition of enzyme activity, corresponding to 50% inhibition of relaxation of supercoiled SV40 DNA under the conditions used.
Cytotoxic Activity Test Cytotoxicity was measured by the microculture tetrazolium assay as described.
14) Growth inhibition experiments were carried out in 96-well (flat bottom) microplates (Falcon California, U.S.A.), and the amount of viable cells at the end of the incubation was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Thus, tumor cells (5.0ϫ10
2 Ϫ5ϫ10 3 cells/150 ml/well) were cultivated in supplement with 10% fetal calf serum, 2 mM L-glutamine, and 100 mg/ml kanamycin sulfate for 24 h, except P388 (2 h) prior to exposure to drugs. Graded concentrations of drugs (50 ml/well) were introduced to the cell culture and the wells were incubated for 3 d. After MTT (50 ml, 20 mg/ml in phosphate-buffered saline) was added to each culture well and the plates were incubated for an additional 4 h, the culture was centrifuged (800ϫg, 5 min) and medium were removed. The formazan product was dissolved in DMSO (150 ml/well) and the absorbance was measured at 540 nm using a Microplate Reader (model 3550 Bio-Rad, California, U.S.A.). Each data point on growth curves was an average of four wells. A measure was also made of the cell population density at time 0 (the time at which drugs were added). Concentration for 50% growth inhibition (GI 50 ) was calculated from the reduction of optical density of treated cells with respect to the density of untreated controls.
Antitumor Activity Test The assay for P388 leukemia in mice was conducted as specified in the standard NCI protocols. 16) P388 Cells (1ϫ10 6 ) were inoculated interperitoneally (i.p.) into CDF1 male mice on day 0 and mice were divided into several groups (6 mice per group) on day 1. Test compounds were suspended in BTC solution (0.9% benzylalcohol, 0.4% Tween 80, 0.5% CMC, 0.97% NaCl) by sonification and given i.p. on days 1 and 5. The control group was given 10 6 tumor cells i.p. and injected with BTC solution (10 ml/kg) on the scheduled days. Survival was monitored daily and the ILS was calculated using the following formula: ILS (%)ϭ [(median survival time of treated group)/(median survival time of control group)ϩ1]ϫ100. Statistical analysis was carried out by the WilliamsWilcoxon test.
